Duthie, Malcolm S.

Use of defined TLR ligands as adjuvants within human vaccines

Duthie, M. S., Windish, H. P., Fox, C. B., & Reed, S. G. (2011) · Immunological Reviews

Immunotherapy and Immune ResponsesImmune Response and Inflammation

Cited by 437

An Alphavirus -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates

Erasmus, J. H., Khandhar, A. P., O’Connor, M. A., Walls, A. C., Hemann, E. A., Murapa, P., Archer, J., Leventhal, S., Fuller, J. T., Lewis, T. B., et al. (2020) · Science Translational Medicine

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 241

A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation

Kimura, T., Leal, J. M., Simpson, A., Warner, N. L., Berube, B. J., Archer, J. F., Park, S., Kurtz, R., Hinkley, T., Nicholes, K., et al. (2023) · Molecular Therapy

RNA Interference and Gene DeliveryImmunotherapy and Immune Responses

Cited by 52

Skin tests for the detection of Mycobacterial infections: achievements, current perspectives, and implications for other diseases

Duthie, M. S., & Reed, S. G. (2021) · Applied Microbiology and Biotechnology

Tuberculosis Research and EpidemiologyMycobacterium research and diagnosis

Cited by 15